Beyond Air (XAIR) Cash from Operations Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | 54.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.96% |
| Sep 30, 2025 | 88.47% |
| Jun 30, 2025 | 55.80% |
| Mar 31, 2025 | 35.30% |
| Dec 31, 2024 | 88.04% |
| Sep 30, 2024 | 83.47% |
| Jun 30, 2024 | 40.65% |
| Mar 31, 2024 | -27.07% |
| Dec 31, 2023 | -62.38% |
| Sep 30, 2023 | -101.02% |
| Jun 30, 2023 | -150.77% |
| Mar 31, 2023 | -6.84% |
| Dec 31, 2022 | -235.06% |
| Sep 30, 2022 | -242.46% |
| Jun 30, 2022 | -74.58% |
| Mar 31, 2022 | -41.86% |
| Dec 31, 2021 | 219.68% |
| Sep 30, 2021 | 250.58% |
| Jun 30, 2021 | 28.57% |
| Mar 31, 2021 | -14.60% |
| Dec 31, 2020 | -10.65% |
| Sep 30, 2020 | -21.92% |
| Jun 30, 2020 | -88.51% |
| Mar 31, 2020 | -168.55% |
| Dec 31, 2019 | -189.85% |
| Sep 30, 2019 | -51.06% |
| Jun 30, 2019 | -26.29% |
| Mar 31, 2019 | 505.21% |
| Dec 31, 2018 | 66.55% |
| Sep 30, 2018 | -28.78% |
| Jun 30, 2018 | -35.45% |
| Mar 31, 2018 | 20.92% |
| Dec 31, 2017 | -1,671.35% |
| Sep 30, 2017 | -1,150.00% |
| Jun 30, 2017 | -1,405.31% |
| Mar 31, 2017 | -1,064.42% |